Status:
NOT_YET_RECRUITING
SALT in Adolescents With End-stage Liver Disease
Lead Sponsor:
RenJi Hospital
Conditions:
End Stage Liver DIsease
Eligibility:
All Genders
7-18 years
Phase:
NA
Brief Summary
End-stage liver disease is synonymous with advanced liver disease, liver failure, and decompensated cirrhosis, and their disease progression is generally irreversible. Unlike other end-stage diseases,...
Detailed Description
Cirrhosis is an irreversible advanced stage of chronic progressive liver disease characterized by structural deformation of the liver and the formation of regenerative nodules. Those with complication...
Eligibility Criteria
Inclusion
- Age 7-18 years old;
- Patients with end-stage liver disease cannot obtain sufficient donor liver volume through conventional living donor liver transplantation;
- The general condition is good and can tolerate the follow-up operation plan;
- Guardians and children (over 14 years old) sign the informed consent.
Exclusion
- Uncorrectable cardiopulmonary disease with excessive surgical risk
- Anatomical abnormalities precluding liver transplantation
- Patients with primary or secondary hepatic malignancies
- Patients with genetic metabolic diseases and their complications that cannot be completely cured by liver transplantation
- Persistent non-adherence to medical care
- Combined with AIDS and other diseases that affect surgery or tumor progression
- Other reasons that the researchers think are not suitable for participation.
Key Trial Info
Start Date :
October 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06069050
Start Date
October 20 2023
End Date
March 30 2027
Last Update
October 5 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.